title: Is risk of neuroleptic malignant syndrome increased in the postpartum period?
authors.forename: P J
authors.initials: PJ
authors.lastname: Alexander
authors.forename: R M
authors.initials: RM
authors.lastname: Thomas
authors.forename: A
authors.initials: A
authors.lastname: Das
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000453:epidemiology; D009459:Neuroleptic Malignant Syndrome / Q000453:epidemiology* / Q000209:etiology; D011446:Prospective Studies; D011644:Puerperal Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000453:epidemiology*; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents